Denmark introduced that it has quickly suspended use of the Oxford-AstraZeneca covid-19 vaccine as a precautionary transfer after experiences of blood clots and one demise.
Nonetheless, the European Medicines Company (EMA) and the UK’s regulatory physique have mentioned that there isn’t any indication that vaccination is linked to thromboembolic occasions.
Seven different international locations—Norway, Iceland, Austria, Estonia, Lithuania, Luxembourg, and Latvia—have additionally suspended use of AstraZeneca’s vaccine.
The choices are an additional setback for Europe’s vaccination marketing campaign, which has struggled to choose up pace, partly due to delays in delivering the AstraZeneca vaccine.The Danish Well being Authority mentioned that one particular person in Denmark had died after receiving the AstraZeneca vaccine and that it will droop the drug’s use for 2 weeks whereas the case was investigated.
“You will need to level out that we have now not terminated the usage of the AstraZeneca vaccine—we’re simply pausing its use,” mentioned the Danish Well being Authority’s director, Soren Brostrøm.Phil Bryan, vaccines security lead for the UK’s Medicines and Healthcare Merchandise Regulatory Company, mentioned, “Greater than 11 million doses of the AstraZeneca vaccine have now been administered throughout the UK.
Studies of blood clots acquired to date should not higher than the quantity that might have occurred naturally within the vaccinated inhabitants.” He added that the company was preserving the problem underneath shut evaluation however that obtainable proof didn’t verify that the vaccine was the trigger.
A spokesperson for AstraZeneca mentioned, “Affected person security is the best precedence for AstraZeneca. Regulators have clear and stringent efficacy and security requirements for the approval of any new medication, and that features Covid-19 Vaccine AstraZeneca.
The protection of the vaccine has been extensively studied in part III medical trials, and peer reviewed information confirms the vaccine has been usually effectively tolerated.”Commenting on the selections, Stephen Evans, professor of pharmacoepidemiology on the London College of Hygiene & Tropical Drugs, mentioned, “The issue with spontaneous experiences of suspected antagonistic reactions to a vaccine [is] the big issue of distinguishing a causal impact from a coincidence.”
He highlighted that covid-19 illness was very strongly related to blood clotting and that there had been a whole bunch, if not many hundreds, of deaths attributable to blood clotting on account of covid-19.
Adam Finn, professor of paediatrics on the College of Bristol, mentioned, “The place with the Oxford-AstraZeneca vaccine in the intervening time is that there isn’t any signal anyplace, together with the UK the place very massive numbers of doses have now been given, that blood clot associated sicknesses are taking place any extra often than ordinary.
“That’s reassuring, as a result of it means both that the vaccine doesn’t trigger blood clots in any respect or, on the very worst, that it’s a particularly uncommon occasion.”